Figure 3.
OS by therapy received. OS by regimen in patients with TP53mut VAF ≤40% (A) and >40% (B). VEN, venetoclax.

OS by therapy received. OS by regimen in patients with TP53mut VAF ≤40% (A) and >40% (B). VEN, venetoclax.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal